Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK3486 versus propofol for induction of general anesthesia in tumor surgery patients
ChiCTR2200066719Phase 4Recruiting
- Sponsor
- Cancer Hospital of Guangxi Medical University
- Start
- Dec 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in thyroid cancer and breast cancer comparing HSK3486 group with Propofol group (2 arms). Primary endpoints: Success rate of induction of anesthesia, Heart rate and 1 more. Started Dec 2022; status: recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
thyroid cancerbreast cancer
Beyond the preview
Go deeper on ChiCTR2200066719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066719.